146 related articles for article (PubMed ID: 36207246)
1. [Alpha-blockers or hexanic extract of Serenoa repens for 6 months: sub-analysis of the PERSAT study].
de la Taille A; Chalret du Rieu Q; Dialla O; Bardin L
Prog Urol; 2023 Feb; 33(2):66-72. PubMed ID: 36207246
[TBL] [Abstract][Full Text] [Related]
2. [Alpha-blockers or phytotherapy as first-line treatment of LUTS/BPH in general medicine: The PERSAT non-interventional study].
de la Taille A; Bardin L; Castagné C; Auges M; Capronnier O; Chalret du Rieu Q
Prog Urol; 2020 Sep; 30(10):522-531. PubMed ID: 32753297
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of a hexanic extract of Serenoa repens (Permixon
Vela-Navarrete R; Alcaraz A; Rodríguez-Antolín A; Miñana López B; Fernández-Gómez JM; Angulo JC; Castro Díaz D; Romero-Otero J; Brenes FJ; Carballido J; Molero García JM; Fernández-Pro Ledesma A; Cózar Olmos JM; Manasanch Dalmau J; Subirana Cachinero I; Herdman M; Ficarra V
BJU Int; 2018 Dec; 122(6):1049-1065. PubMed ID: 29694707
[TBL] [Abstract][Full Text] [Related]
4. Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment--the QUALIPROST study.
Alcaraz A; Carballido-Rodríguez J; Unda-Urzaiz M; Medina-López R; Ruiz-Cerdá JL; Rodríguez-Rubio F; García-Rojo D; Brenes-Bermúdez FJ; Cózar-Olmo JM; Baena-González V; Manasanch J
Int Urol Nephrol; 2016 May; 48(5):645-56. PubMed ID: 26810324
[TBL] [Abstract][Full Text] [Related]
5. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials.
Russo GI; Scandura C; Di Mauro M; Cacciamani G; Albersen M; Hatzichristodoulou G; Fode M; Capogrosso P; Cimino S; Marcelissen T; Cornu JN; Gacci M; Minervini A; Cocci A;
Eur Urol Focus; 2021 Mar; 7(2):420-431. PubMed ID: 31952967
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients.
Alcaraz A; Rodríguez-Antolín A; Carballido-Rodríguez J; Castro-Díaz D; Medina-Polo J; Fernández-Gómez JM; Ficarra V; Palou J; Ponce de León Roca J; Angulo JC; Esteban-Fuertes M; Cózar-Olmo JM; Pérez-León N; Molero-García JM; Fernández-Pro Ledesma A; Brenes-Bermúdez FJ; Manasanch J
Sci Rep; 2021 Sep; 11(1):19401. PubMed ID: 34588509
[TBL] [Abstract][Full Text] [Related]
7. [Interest of a systematic assessment of the treatment of the lower urinary tract symptoms in the management of benign prostatic hypertrophy in general practice (1380 patients) - Study EVALURO].
Descazeaud A; Coloby P; De La Taille A; Kouri G; Mallet R; Rossi D; Rozet F; Zerbib M; Carrois F
Prog Urol; 2019 Feb; 29(2):116-126. PubMed ID: 30665818
[TBL] [Abstract][Full Text] [Related]
8. Effects of hexanic extract of Serenoa repens (Permixon® 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia.
Latil A; Pétrissans MT; Rouquet J; Robert G; de la Taille A
Prostate; 2015 Dec; 75(16):1857-67. PubMed ID: 26306400
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of the Hexanic Extract of
Alcaraz A; Gacci M; Ficarra V; Medina-Polo J; Salonia A; Fernández-Gómez JM; Ciudin A; Castro-Díaz D; Rodríguez-Antolín A; Carballido-Rodríguez J; Cózar-Olmo JM; Búcar-Terrades S; Pérez-León N; Brenes-Bermúdez FJ; Molero-García JM; Ledesma AF; Herdman M; Manasanch J; Angulo JC; Group OBOTQS
J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207238
[TBL] [Abstract][Full Text] [Related]
10. Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review.
MacDonald R; Tacklind JW; Rutks I; Wilt TJ
BJU Int; 2012 Jun; 109(12):1756-61. PubMed ID: 22551330
[TBL] [Abstract][Full Text] [Related]
11. Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study.
Alcaraz A; Rodríguez-Antolín A; Carballido-Rodríguez J; Castro-Díaz D; Esteban-Fuertes M; Cózar-Olmo JM; Ficarra V; Medina-López R; Fernández-Gómez JM; Angulo JC; Medina-Polo J; Brenes-Bermúdez FJ; Molero-García JM; Fernández-Pro-Ledesma A; Manasanch J; The Qualiprost Study Group OBO
J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32917008
[TBL] [Abstract][Full Text] [Related]
12. Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.
Bertaccini A; Giampaoli M; Cividini R; Gattoni GL; Sanseverino R; Realfonso T; Napodano G; Fandella A; Guidoni E; Prezioso D; Galasso R; Cicalese C; Scattoni V; Armenio A; Conti G; Corinti M; Spasciani R; Liguori G; Lampropoulou N; Martorana G
Arch Ital Urol Androl; 2012 Sep; 84(3):117-22. PubMed ID: 23210402
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of
Alcaraz A; Castro-Díaz D; Gacci M; Salonia A; Ficarra V; Carballido-Rodríguez J; Rodríguez-Antolín A; Medina-Polo J; Fernández-Gómez JM; Cózar-Olmo JM; Búcar-Terrades S; Pérez-León N; Brenes-Bermúdez FJ; Molero-García JM; Fernández-Pro-Ledesma A; Herdman M; Angulo JC; Manasanch J; On Behalf Of The Qualiprost Study Group
J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35806900
[TBL] [Abstract][Full Text] [Related]
14. Hexanic Extract of Serenoa repens (Permixon
Blair HA
Drugs Aging; 2022 Mar; 39(3):235-243. PubMed ID: 35237936
[TBL] [Abstract][Full Text] [Related]
15. The Role of Combination Therapy with α-Blockers and Hexanic Extract of
De Nunzio C; Salonia A; Gacci M; Ficarra V
J Clin Med; 2022 Dec; 11(23):. PubMed ID: 36498751
[TBL] [Abstract][Full Text] [Related]
16. Serenoa repens for benign prostatic hyperplasia.
Tacklind J; MacDonald R; Rutks I; Wilt TJ
Cochrane Database Syst Rev; 2009 Apr; (2):CD001423. PubMed ID: 19370565
[TBL] [Abstract][Full Text] [Related]
17. Serenoa repens for benign prostatic hyperplasia.
Wilt T; Ishani A; Mac Donald R
Cochrane Database Syst Rev; 2002; (3):CD001423. PubMed ID: 12137626
[TBL] [Abstract][Full Text] [Related]
18. Clinical Effects of Oral Supplementation of Gamma-Cyclodextrin Curcumin Complex in Male Patients with Moderate-To-Severe Benign Prostatic Hyperplasia-Related Lower Urinary Tract Symptoms.
Crocerossa F; Cantiello F; Bagalá L; Sicoli F; Carbonara U; Manfredi C; Falagario U; Veccia A; Pandolfo SD; Napolitano L; Ferro M; Di Dio M; Mondaini N; Damiano R
Urol Int; 2023; 107(10-12):924-934. PubMed ID: 37939691
[TBL] [Abstract][Full Text] [Related]
19. Comparison of tamsulosin plus serenoa repens with tamsulosin in the treatment of benign prostatic hyperplasia in Korean men: 1-year randomized open label study.
Ryu YW; Lim SW; Kim JH; Ahn SH; Choi JD
Urol Int; 2015; 94(2):187-93. PubMed ID: 25614155
[TBL] [Abstract][Full Text] [Related]
20. Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone.
Boeri L; Capogrosso P; Ventimiglia E; Cazzaniga W; Pederzoli F; Moretti D; Dehò F; Montanari E; Montorsi F; Salonia A
Sci Rep; 2017 Nov; 7(1):15179. PubMed ID: 29123161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
